These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 8894583)

  • 21. In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial.
    Gootz TD; Brighty KE; Anderson MR; Schmieder BJ; Haskell SL; Sutcliffe JA; Castaldi MJ; McGuirk PR
    Diagn Microbiol Infect Dis; 1994 Aug; 19(4):235-43. PubMed ID: 7851087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2471-6. PubMed ID: 7840591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of ciprofloxacin against aerobic gram-negative bacteria.
    Rudin JE; Norden CW; Shinners EM
    Antimicrob Agents Chemother; 1984 Oct; 26(4):597-8. PubMed ID: 6517550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa.
    Giamarellou H; Petrikkos G
    Antimicrob Agents Chemother; 1987 Jun; 31(6):959-61. PubMed ID: 3113330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergism of the combinations of imipenem plus ciprofloxacin and imipenem plus amikacin against Pseudomonas aeruginosa and other bacterial pathogens.
    Bustamante CI; Drusano GL; Wharton RC; Wade JC
    Antimicrob Agents Chemother; 1987 Apr; 31(4):632-4. PubMed ID: 3111357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
    Bamberger DM; Peterson LR; Gerding DN; Moody JA; Fasching CE
    J Antimicrob Chemother; 1986 Jul; 18(1):51-63. PubMed ID: 3093445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive evaluation of ciprofloxacin in combination with beta-lactam antibiotics against Enterobacteriaceae and Pseudomonas aeruginosa.
    Haller I
    Arzneimittelforschung; 1986 Feb; 36(2):226-9. PubMed ID: 2938593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains.
    Haller I
    Antimicrob Agents Chemother; 1985 Nov; 28(5):663-6. PubMed ID: 2936301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches.
    Ball P
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():165-79. PubMed ID: 2127272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of trovafloxacin in combination with ceftazidime, meropenem, and amikacin.
    Milatovic D; Wallrauch C
    Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):688-93. PubMed ID: 8894583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New antibiotics.
    Friedland IR; Lutsar I
    Curr Opin Pediatr; 1998 Feb; 10(1):41-5. PubMed ID: 9529636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chemistry and biological profile of trovafloxacin.
    Brighty KE; Gootz TD
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():1-14. PubMed ID: 9222064
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.